Treating Oxidative Stress and the Metabolic Pathology of Autism

Completed · Not applicable · Has a placebo group

Conditions studied: Autistic Disorder

In brief

Hypothesis: Many children with autism have impaired methylation and antioxidant/detoxification capacity and chronic oxidative stress. A targeted nutritional intervention that is designed to correct the metabolic imbalance will normalize their metabolic profile and improve measures of autistic behavior.

Key facts

Study ID

NCT00572741

Run by

Arkansas Children's Hospital Research Institute

People needed

39

Starts

2008-06-01

Expected to finish

2016-04-01

Last updated by the study team

2016-05-05

Who can join

Age: 3 and older, up to 7. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ADOS and DSM-IV (299.0) diagnosis of Autistic Disorder
• Both sexes
• Age range 3-7

You may not qualify if…

• Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS)
• Asperger's
• Rett syndrome
• Fragile X
• Tuberous sclerosis or other genetic conditions associated with autism
• Frequent seizures
• Recurrent or current infection
• Severe gastrointestinal distress
• Recent supplement use

Where it is running

• Arkansas Children's Hospital Research Institute — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.